Results of the CUR domain and the member survey done there answer this question perfectly.
Table 1: “Overview of CRC screening practices in European countries” in CUR show that FIT is already used in several regions. So no new far reaching consequences on health care are to be expected.
Endel G Result Card ETH1 In: Endel G Ethical analysis In: Jefferson T, Cerbo M, Vicari N [eds.]. Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali; 2014. [cited 21 June 2021]. Available from: http://corehta.info/ViewCover.aspx?id=206